{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T12:35:05Z","timestamp":1762432505234,"version":"3.37.3"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T00:00:00Z","timestamp":1718755200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32102701"],"award-info":[{"award-number":["32102701"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFD1602201","2022YFD16022"],"award-info":[{"award-number":["2022YFD1602201","2022YFD16022"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal for Parasitology: Drugs and Drug Resistance"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.ijpddr.2024.100552","type":"journal-article","created":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T16:41:34Z","timestamp":1718901694000},"page":"100552","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["In vitro and in vivo activity evaluation and mode of action of broxaldine on Toxoplasma gondii"],"prefix":"10.1016","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-7403-3953","authenticated-orcid":false,"given":"Yanhua","family":"Qiu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6378-2527","authenticated-orcid":false,"given":"Bintao","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6855-8524","authenticated-orcid":false,"given":"Yubin","family":"Bai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongling","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingyu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengyan","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shulin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpddr.2024.100552_bib1","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ejogrb.2020.10.003","article-title":"Toxoplasmosis in pregnancy","volume":"255","author":"Ahmed","year":"2020","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"10.1016\/j.ijpddr.2024.100552_bib2","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2147\/DDDT.S60973","article-title":"Drugs in development for toxoplasmosis: advances, challenges, and current status","volume":"11","author":"Alday","year":"2017","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.ijpddr.2024.100552_bib3","doi-asserted-by":"crossref","first-page":"680","DOI":"10.3390\/cells8070680","article-title":"Mitochondria in health and disease","volume":"8","author":"Annesley","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.ijpddr.2024.100552_bib4","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.biopha.2016.05.041","article-title":"Human toxoplasmosis - Searching for novel chemotherapeutics","volume":"82","author":"Antczak","year":"2016","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ijpddr.2024.100552_bib5","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.3390\/pharmaceutics14081634","article-title":"Drug repurposing based on protozoan proteome: In vitro evaluation of in silico screened compounds against Toxoplasma gondii","volume":"14","author":"Cajazeiro","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijpddr.2024.100552_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.902428","article-title":"Modulation of autophagy as a therapeutic strategy for Toxoplasma gondii infection","volume":"12","author":"Cheng","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.ijpddr.2024.100552_bib7","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.jpsychires.2022.07.013","article-title":"Association between toxoplasmosis and bipolar disorder : a systematic review and meta-analysis","volume":"153","author":"Cossu","year":"2022","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.ijpddr.2024.100552_bib8","doi-asserted-by":"crossref","first-page":"e00017","DOI":"10.1128\/CMR.00057-17","article-title":"Treatment of toxoplasmosis: historical perspective, animal models, and current clinical practice","volume":"31","author":"Dunay","year":"2018","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.ijpddr.2024.100552_bib9","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.3390\/antiox11101888","article-title":"Identification of cytoprotective small-molecule inducers of Heme-Oxygenase-1","volume":"11","author":"Ghajar-Rahimi","year":"2022","journal-title":"Antioxidants"},{"key":"10.1016\/j.ijpddr.2024.100552_bib10","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0020-7519(99)00170-8","article-title":"Identification of a 200- to 300-fold repetitive 529 bp DNA fragment in Toxoplasma gondii, and its use for diagnostic and quantitative PCR","volume":"30","author":"Homan","year":"2000","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.ijpddr.2024.100552_bib11","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1645\/19-152","article-title":"Video microscopic analysis of invasion of Toxoplasma gondii into peritoneal macrophages","volume":"106","author":"Jin","year":"2020","journal-title":"J. Parasitol."},{"key":"10.1016\/j.ijpddr.2024.100552_bib12","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0920-9964(02)00357-2","article-title":"Drugs used in the treatment of schizophrenia and bipolar disorder inhibit the replication of Toxoplasma gondii","volume":"62","author":"Jones-Brando","year":"2003","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.ijpddr.2024.100552_bib13","doi-asserted-by":"crossref","first-page":"e01819","DOI":"10.1128\/AAC.01889-19","article-title":"Hydroxylamine and carboxymethoxylamine can inhibit Toxoplasma gondii growth through an aspartate aminotransferase-independent pathway","volume":"64","author":"Li","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2024.100552_bib14","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.pt.2019.07.001","article-title":"Toxoplasma gondii","volume":"35","author":"Lourido","year":"2019","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.ijpddr.2024.100552_bib15","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1159\/000219939","article-title":"Fecal flora in protozoal and common colitis. Changes after therapeutic use of intestinal antiseptics","volume":"4","author":"Maiamos","year":"1962","journal-title":"II. AI 307 (Intestopan). Chemotherapia (Basel)"},{"key":"10.1016\/j.ijpddr.2024.100552_bib16","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/978-1-4939-9857-9_15","article-title":"Toxoplasma gondii: bradyzoite differentiation in vitro and in vivo","volume":"2071","author":"Mayoral","year":"2020","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ijpddr.2024.100552_bib17","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.pt.2020.08.005","article-title":"Toxoplasma gondii: an underestimated threat?","volume":"36","author":"Milne","year":"2020","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.ijpddr.2024.100552_bib18","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.3389\/fmicb.2018.02587","article-title":"Drug resistance in Toxoplasma gondii","volume":"9","author":"Montazeri","year":"2018","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.ijpddr.2024.100552_bib19","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1016\/S0140-6736(04)16412-X","article-title":"Toxoplasmosis","volume":"363","author":"Montoya","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.ijpddr.2024.100552_bib20","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/s41467-020-20381-z","article-title":"ATP synthase hexamer assemblies shape cristae of Toxoplasma mitochondria","volume":"12","author":"Muhleip","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijpddr.2024.100552_bib21","article-title":"Is Toxoplasma gondii a potential risk factor for Alzheimer's disease? A systematic review and meta-analysis","volume":"137","author":"Nayeri","year":"2019","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.ijpddr.2024.100552_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2020.104434","article-title":"Relationship between toxoplasmosis and autism: a systematic review and meta-analysis","volume":"147","author":"Nayeri","year":"2020","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.ijpddr.2024.100552_bib23","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.69182","article-title":"Blood-brain barrier -restricted translocation of Toxoplasma gondii from cortical capillaries","volume":"10","author":"Olivera","year":"2021","journal-title":"Elife"},{"key":"10.1016\/j.ijpddr.2024.100552_bib24","first-page":"1102","article-title":"[Clinical data on a new intestinal antiseptic: Intestopan (AI-307)]","volume":"66","author":"Russo","year":"1962","journal-title":"Gazz. Int. Med. e Chir."},{"key":"10.1016\/j.ijpddr.2024.100552_bib25","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S0140-6736(75)91334-3","article-title":"Letter: effect of broxyquinoline and broxaldine in leprosy","volume":"1","author":"Sharma","year":"1975","journal-title":"Lancet"},{"key":"10.1016\/j.ijpddr.2024.100552_bib26","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.ijpddr.2018.02.006","article-title":"Licochalcone A: an effective and low-toxicity compound against Toxoplasma gondii in vitro and in vivo","volume":"8","author":"Si","year":"2018","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"key":"10.1016\/j.ijpddr.2024.100552_bib27","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.pt.2005.11.001","article-title":"Lipid biology of Apicomplexa: perspectives for new drug targets, particularly for Toxoplasma gondii","volume":"22","author":"Sonda","year":"2006","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.ijpddr.2024.100552_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003823","article-title":"The Toxoplasma gondii cyst wall protein CST1 is critical for cyst wall integrity and promotes bradyzoite persistence","volume":"9","author":"Tomita","year":"2013","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ijpddr.2024.100552_bib29","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/med.10016","article-title":"Chloroquine resistance in the malarial parasite, Plasmodium falciparum","volume":"22","author":"Ursos","year":"2002","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ijpddr.2024.100552_bib30","doi-asserted-by":"crossref","DOI":"10.1111\/jeu.12906","article-title":"Parasite powerhouse : a review of the Toxoplasma gondii mitochondrion","volume":"69","author":"Usey","year":"2022","journal-title":"J. Eukaryot. Microbiol."},{"key":"10.1016\/j.ijpddr.2024.100552_bib31","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.3390\/cells10051053","article-title":"1,3,4-Thiadiazoles effectively inhibit proliferation of Toxoplasma gondii","volume":"10","author":"W\u0119gli\u0144ska","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.ijpddr.2024.100552_bib32","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1146\/annurev-micro-020518-115546","article-title":"Molecular mechanisms of drug resistance in Plasmodium falciparum malaria","volume":"74","author":"Wicht","year":"2020","journal-title":"Annu. Rev. Microbiol."}],"container-title":["International Journal for Parasitology: Drugs and Drug Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211320724000332?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211320724000332?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T06:15:49Z","timestamp":1723011349000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211320724000332"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":32,"alternative-id":["S2211320724000332"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpddr.2024.100552","relation":{},"ISSN":["2211-3207"],"issn-type":[{"type":"print","value":"2211-3207"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vitro and in vivo activity evaluation and mode of action of broxaldine on Toxoplasma gondii","name":"articletitle","label":"Article Title"},{"value":"International Journal for Parasitology: Drugs and Drug Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpddr.2024.100552","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Ltd on behalf of Australian Society for Parasitology.","name":"copyright","label":"Copyright"}],"article-number":"100552"}}